InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold Post author:Sam Post published:March 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca Partners Up With Chinese Fund to Launch New Biopharma Company November 26, 2017 Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017 Reunited and It Feels So Good: After the Success of Serial Biotech Duo Launches February 8, 2017
Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017